| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $336K | -0.8% | -1.7% |
| Cost of Revenue | $65K | -2.5% | -40.9% |
| Gross Profit | $271K | -0.4% | +16.8% |
| R&D Expense | $73K | +26.3% | — |
| SG&A Expense | $1.1M | -21.6% | +88.5% |
| Pre-tax Income | -$1.0M | +20.7% | -167.3% |
| Net Income | -$1.0M | +20.7% | -163.7% |
| EPS (Basic) | -$0.08 | +27.3% | -100.0% |
| EPS (Diluted) | -$0.08 | +27.3% | -100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $216K | -18.0% | +20.4% |
| Accounts Receivable | $13K | — | — |
| Current Assets | $1.1M | -49.6% | +196.4% |
| Total Assets | $3.0M | -25.6% | +710.8% |
| Current Liabilities | $641K | +0.6% | -33.5% |
| Total Liabilities | $641K | +0.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.9M | -91.2% | — |
| Capital Expenditures | $1.2M | +0.0% | — |
| Investing Cash Flow | -$1.7M | -4.4% | — |
| Financing Cash Flow | -$3K | — | — |
| Free Cash Flow | -$3.1M | -42.2% | — |
| -33.5% |
| Stockholders' Equity | $2.3M | -30.5% | +492.6% |